Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.0062 | 0.9 |
mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.006 | 0.9 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |